Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by alterations in motor capacity resulting from a decrease in the neurotransmitter dopamine due to the selective death of dopaminergic neurons of the nigrostriatal pathway. Unfortunately, conventional pharmacological treatments f...
Saved in:
Main Authors: | María Fernanda Urmeneta-Ortíz, Aldo Rafael Tejeda-Martínez, Orfil González-Reynoso, Mario Eduardo Flores-Soto |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2024/5519396 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
by: Edward C. Lauterbach, et al.
Published: (2012-01-01) -
Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson’s Disease
by: Jason R. Richardson, et al.
Published: (2013-01-01) -
Endocannabinoids and Reproduction
by: Rosaria Meccariello, et al.
Published: (2014-01-01) -
Cannabinoids and the endocannabinoid system in liver diseases
by: Anna Parfieniuk-Kowerda, et al.
Published: (2024-12-01) -
Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
by: François-Xavier Blaudin de Thé, et al.
Published: (2016-01-01)